Type 2 diabetes
| Age | 0 - 9 | 10 - 14 | 15 - 19 | 20 - 24 | 25 - 29 | 30 - 34 | 35 - 39 | 40 - 44 | 45 - 49 | 50 - 54 | 55 - 59 | 60 - 64 | 65 - 69 | 70 - 79 | >80 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X | X | X | X | X | X | X | X | ||||||||
| * | 17 | X | X | X | X | X | X | X | X | X | X | X | X |
* Aboriginal people and Torres Strait Islanders
Patients should be screened for diabetes every 3 years from 40 years of age using the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) (A). Aboriginal people or Torres Strait Islanders should be screened from 18 years of age. Those with a risk score of 15 or more should be tested by fasting plasma glucose (B).
| Who is at higher risk of type 2 diabetes? | What should be done? | How often? | Level of evidence and references |
|---|---|---|---|
Increased risk
|
AUSDRISK (see Appendix 2) |
Every 3 years |
III B 321 |
High risk
|
Fasting plasma sugar |
Every 3 years |
III B 321,322 |
| Test | Technique | References |
|---|---|---|
| Fasting blood sugar | Measure plasma glucose levels preferably on a fasting sample, although a ‘random’ sample is acceptable for screening purposes.
The test should be performed on venous blood and tested in a laboratory. However, capillary blood and a properly calibrated point of care device may be used for screening (if a laboratory is used to confirm a positive result) |
321 |
| Oral glucose tolerance test | Two hours after a 75 g oral glucose load is taken, the plasma glucose is measured. If this is >11.1 mmol/L, diabetes is likely. If it is between 7.8 and 11.0 mmol/L then there is impaired glucose tolerance. If it is <7.8 mmol/L diabetes is unlikely | 321 |
| Diabetes risk (AUSDRISK assessment tool) | Diabetes risk may be calculated using the AUSDRISK assessment tool. This calculates a score related to the risk of developing diabetes over a 5 year period based on cohort data for that population (see Appendix 2) (The tool may underestimate risk below the age of 25 years) | 323 |
| Glycosylated haemoglobin (HbA1c) | This is not currently recommended as a test to diagnose diabetes as the appropriate cut off is still to be determined | 324 325 |
Prevention of diabetes
| Target group | Intervention | References |
|---|---|---|
| Pre-diabetes (IGT, IFG, GDM) and those with identified risk factors with negative screening test |
|
327-329 |
© The Royal Australian College of General Practitioners
Printed from www.racgp.org.au/redbook



